Related Experiment Video
Updated: Jul 26, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Growth hormone treatment in Léri-Weill syndrome
I J Thuestad1, S A Ivarsson, K O Nilsson
1Department of Pediatrics, University of Lund, University Hospital, Malmö, Sweden.
Abstract:
Five children with dyschondrosteosis (Léri-Weill syndrome) were found to have insufficient growth hormone (GH) secretion and were treated with GH. After one year of treatment height velocity SDS as well as height SDS increased significantly. In three children who had completed their second year of treatment, the increase in height velocity was sustained and for all patients predicted adult height increased during the GH treatment.
More Related Videos
Related Concept Videos
Gene Therapy
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Cushing Syndrome II: Pathophysiology

